Ascelia Pharma
Sweden - MalmöPharmaceutical
Focus: Ascelia Pharma is a Swedish-listed pharmaceutical company focused on MRI imaging drugs, specifically in gastroenterology. The company operates at a lean scale with a single Phase 3 program in development.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Ascelia Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Ascelia Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Ascelia Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
mangoral
Focal Liver LesionsClinical Trials (1)
NCT04119843Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function
Phase 3Help build intelligence for Ascelia Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.